Consentement d'utilisation des Cookies

J'accepte Notre site sauvegarde des traceurs textes (cookies) sur votre appareil afin de vous garantir de meilleurs contenus et à des fins de collectes statistiques.Vous pouvez désactiver l'usage des cookies en changeant les paramètres de votre navigateur. En poursuivant votre navigation sur notre site sans changer vos paramètres de navigateur vous nous accordez la permission de conserver des informations sur votre appareil.

14611-52-0 - (R)-(-)-Deprenyl hydrochloride - Selegiline - J61286 - Alfa Aesar

J61286 (R)-(-)-Deprenyl hydrochloride

Numéro CAS
14611-52-0
Synonymes
Selegiline

Dimensions Prix ($) Quantité Disponibilité
250mg 66,40
1g 198,00
Ajouter au panier Ajouter au devis en vrac Afficher l'article

(R)-(-)-Deprenyl hydrochloride

MDL
MFCD00069299

Propriétés chimiques

Formule
C13H17N•HCl
Poids formulaire
223.74
Forme
Crystalline Powder
Solubilité
Soluble in water at 100mM

Applications

(R)-(-)-Deprenyl hydrochloride provides neuroprotection which may be relevant to Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and stroke. It is an inhibitor of MAO-B (monoamine oxidase-B) which demonstrates extensive neuroprotective effects shown to be uncorrelated with MAO-B inhibiting activity. It demonstrates protection of dopaminergic neurons from excitotoxicity mediated by NMDA activation. It also demonstrates decreases in apoptosis of PC12 neuronal cells accompanied with an induction of new protein synthesis through direct transcriptional and translational interaction, and reduced cell death and internucleosomal DNA degredation at concentrations too low to inhibit MAO-B.

Notes

Stable under recommended storage conditions. Incompatible with oxidizing agents.

Références bibliographiques

J.W.Tetrud; J.W.Langston. The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Science. 1989, 245,(4917), 519-522.

 

E.W.Tsang; C.Hamani; E.Moro; F.Mazzella; U.Saha; A.M.Lozano; M.Hodaie; R.Chuang; T.Steeves; S.Y.Lim; B.Neagu; R.Chen. Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease. Neurology. 2012, 78,(24), 1930-1938.

Mentions de danger et de prudence du SGH

Mentions de danger (UE): H315-H319

Causes skin irritation. Causes serious eye irritation.

Mentions de prudence: P280-P264-P305+P351+P338-P362-P321-P332+P313-P337+P313-P302+P352

Wear protective gloves/protective clothing/eye protection/face protection. Wash thoroughly after handling. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Take off contaminated clothing and wash before reuse. Specific treatment (see label). If skin irritation occurs: Get medical advice/attention. If eye irritation persists: IF ON SKIN: Wash with plenty of soap and water.

Autres références

Merck
14,8428
Code tarifaire harmonisé
2921.49
TSCA
No
RTECS
DA0292500

Recommandé

  • A12409

    N-Cyclohexylaniline, 98%
  • A17013

    5,5-Diphenylhydantoin, 99%
  • A17240

    3-Aminobenzeneboronic acid hemisulfate, 98+%
  • 45527

    Carbon black, acetylene, 100% compressed, 99.9+%
  • H53436

    1-Trimethylsilyl-1,4-pentadiyne, 98%

Consulté récemment

Produits chimiques

Sciences de la vie

Métaux et matériaux

Catalyseurs

Analytique et matériel de laboratoire